Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POEMS: Goserelin for Ovarian Failure Prevention in Breast Cancer
NCT00068601Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 2003
- Primary completion
- Jan 2014
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of goserelin in primary ovarian insufficiency (POI), sponsored by SWOG Cancer Research Network. Started Oct 2003; status: completed.
02
Drugs
goserelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00068601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068601.